rs79474211

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_001407021.1(PRKAG2):​c.298G>A​(p.Gly100Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00421 in 1,613,886 control chromosomes in the GnomAD database, including 177 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0031 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 173 hom. )

Consequence

PRKAG2
NM_001407021.1 missense

Scores

1
2
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:19

Conservation

PhyloP100: 2.06

Publications

30 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • PRKAG2-related cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • lethal congenital glycogen storage disease of heart
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
  • Wolff-Parkinson-White syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0072490573).
BP6
Variant 7-151781320-C-T is Benign according to our data. Variant chr7-151781320-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 36697.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0522 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001407021.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
NM_016203.4
MANE Select
c.298G>Ap.Gly100Ser
missense
Exon 3 of 16NP_057287.2
PRKAG2
NM_001407021.1
c.298G>Ap.Gly100Ser
missense
Exon 3 of 15NP_001393950.1
PRKAG2
NM_001407022.1
c.298G>Ap.Gly100Ser
missense
Exon 3 of 15NP_001393951.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
ENST00000287878.9
TSL:1 MANE Select
c.298G>Ap.Gly100Ser
missense
Exon 3 of 16ENSP00000287878.3
PRKAG2
ENST00000392801.6
TSL:1
c.166G>Ap.Gly56Ser
missense
Exon 3 of 16ENSP00000376549.2
PRKAG2
ENST00000488258.5
TSL:1
n.298G>A
non_coding_transcript_exon
Exon 3 of 10ENSP00000420783.1

Frequencies

GnomAD3 genomes
AF:
0.00309
AC:
470
AN:
152010
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000725
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.000866
Gnomad EAS
AF:
0.0359
Gnomad SAS
AF:
0.0342
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0191
Gnomad NFE
AF:
0.000662
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00736
AC:
1846
AN:
250804
AF XY:
0.00854
show subpopulations
Gnomad AFR exome
AF:
0.000557
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.000894
Gnomad EAS exome
AF:
0.0318
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.000891
Gnomad OTH exome
AF:
0.00555
GnomAD4 exome
AF:
0.00432
AC:
6317
AN:
1461758
Hom.:
173
Cov.:
33
AF XY:
0.00518
AC XY:
3766
AN XY:
727176
show subpopulations
African (AFR)
AF:
0.00179
AC:
60
AN:
33478
American (AMR)
AF:
0.00105
AC:
47
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00103
AC:
27
AN:
26136
East Asian (EAS)
AF:
0.0541
AC:
2146
AN:
39700
South Asian (SAS)
AF:
0.0348
AC:
3004
AN:
86258
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53304
Middle Eastern (MID)
AF:
0.0140
AC:
81
AN:
5768
European-Non Finnish (NFE)
AF:
0.000492
AC:
547
AN:
1112000
Other (OTH)
AF:
0.00657
AC:
397
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
428
856
1284
1712
2140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00309
AC:
470
AN:
152128
Hom.:
4
Cov.:
32
AF XY:
0.00382
AC XY:
284
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.000723
AC:
30
AN:
41500
American (AMR)
AF:
0.000981
AC:
15
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.000866
AC:
3
AN:
3464
East Asian (EAS)
AF:
0.0360
AC:
186
AN:
5168
South Asian (SAS)
AF:
0.0343
AC:
165
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.0205
AC:
6
AN:
292
European-Non Finnish (NFE)
AF:
0.000662
AC:
45
AN:
67982
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00267
Hom.:
9
Bravo
AF:
0.00235
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.00801
AC:
972
Asia WGS
AF:
0.0400
AC:
140
AN:
3478
EpiCase
AF:
0.00115
EpiControl
AF:
0.00136

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
4
not provided (4)
-
-
2
Cardiomyopathy (2)
-
1
1
Wolff-Parkinson-White pattern (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Hypertrophic cardiomyopathy 6 (1)
-
-
1
Lethal congenital glycogen storage disease of heart (1)
-
-
1
PRKAG2 cardiac syndrome (1)
-
-
1
Renal cysts and diabetes syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.055
T
Eigen
Benign
0.036
Eigen_PC
Benign
0.082
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.70
T
MetaRNN
Benign
0.0072
T
MetaSVM
Benign
-0.50
T
MutationAssessor
Benign
1.4
L
PhyloP100
2.1
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-0.82
N
REVEL
Pathogenic
0.73
Sift
Benign
0.11
T
Sift4G
Benign
0.14
T
Polyphen
0.91
P
Vest4
0.26
MVP
0.71
MPC
0.14
ClinPred
0.010
T
GERP RS
4.1
Varity_R
0.12
gMVP
0.22
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79474211; hg19: chr7-151478406; COSMIC: COSV55242064; API